Weight loss medications can be lifesaving for people who need them — but there are errors you’ll want to avoid.

Shares of Inspire Medical Systems (NYSE:INSP) slipped on Friday after Jefferies downgraded the MedTech player to Hold from ...

Using semaglutide or tirzepatide for less than 2 years can cost as much as a Roux-en-Y gastric bypass — a one-time procedure ...

USA: A study published in Obesity Pillars has revealed that individuals taking GLP-1 receptor agonists (GLP-1RAs) experienced ...

In the 1980s, scientists made a discovery that would eventually lead to the development of drugs now used worldwide to treat diabetes and to help people manage obesity through weight loss injections.

Adults with pulmonary arterial hypertension using vs. not using GLP-1 receptor agonists had significantly lower relative ...

The produce giant says its Colada Royale pineapple is a “game-changing” innovation that took 15 years to develop, while ...

In the short term, Eli Lilly and Novo Nordisk will continue to dominate due to strong branding and doctor trust. But in the ...

High School Musical' alum Ashley Tisdale said she doesn't judge people who take Ozempic, but it's not the right choice for ...

GLP-1s can cause changes in hydration, nutrition, and GI function that directly affect the mouth. Aminoshariae said these ...

The age of the GLP-1 drug has reached yet another milestone, with the US Food and Drug Administration green-lighting Novo Nordisk's once-daily oral semaglutide pill to treat people at high risk of ...

In 2025, the average annual premium for family health coverage reached $26,993, an increase of $1,408 (6 percent) from the previous year. Covered workers contributed an average of 16 percent ($1,440) ...